VIA OPTRONICS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.18 USD | 0.00% |
|
0.00% | -76.96% |
| Apr. 18 | ADRs End Lower; Genetic Technologies Declines 23% | DJ |
| Apr. 15 | ADRs Slump, VIA Optronics AG Declines 27% | DJ |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 |
|---|---|---|---|
| Capitalization 1 | 249.6 | 146.4 | 33.79 |
| Enterprise Value (EV) 1 | 200.9 | 136.1 | 29.74 |
| P/E ratio | -51.8 x | -12.5 x | -3.22 x |
| Yield | - | - | - |
| Capitalization / Revenue | 1.64 x | 0.81 x | 0.15 x |
| EV / Revenue | 1.32 x | 0.75 x | 0.14 x |
| EV / EBITDA | 28.4 x | -13 x | -10.1 x |
| EV / FCF | 24,412,973 x | -4,603,302 x | -14,049,948 x |
| FCF Yield | 0% | -0% | -0% |
| Price to Book | 3.22 x | 2.25 x | 0.61 x |
| Nbr of stocks (in thousands) | 22,654 | 22,654 | 22,654 |
| Reference price 2 | 11.02 | 6.465 | 1.491 |
| Announcement Date | 4/29/21 | 5/16/22 | 4/26/24 |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 131 | 171.7 | 137.2 | 152.6 | 180.8 | 219.5 |
| EBITDA 1 | 5.568 | 5.195 | -5.536 | 7.067 | -10.47 | -2.956 |
| EBIT 1 | 5.161 | 2.722 | -10.95 | 1.426 | -15.31 | -9.011 |
| Operating Margin | 3.94% | 1.59% | -7.98% | 0.93% | -8.47% | -4.11% |
| Earnings before Tax (EBT) 1 | 4.615 | 3.756 | -12.62 | -2.193 | -10.29 | -8.733 |
| Net income 1 | 3.354 | 3.959 | -11.76 | -3.617 | -11.76 | -10.51 |
| Net margin | 2.56% | 2.31% | -8.57% | -2.37% | -6.5% | -4.79% |
| EPS 2 | 0.2236 | 0.2639 | -0.7861 | -0.2129 | -0.5190 | -0.4638 |
| Free Cash Flow | - | -6.996 | 2.817 | 8.229 | -29.56 | -2.117 |
| FCF margin | - | -4.08% | 2.05% | 5.39% | -16.35% | -0.96% |
| FCF Conversion (EBITDA) | - | - | - | 116.44% | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/5/19 | 4/26/19 | 9/4/20 | 4/29/21 | 5/16/22 | 4/26/24 |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 7.24 | 20.1 | 34.9 | - | - | - |
| Net Cash position 1 | - | - | - | 48.7 | 10.4 | 4.05 |
| Leverage (Debt/EBITDA) | 1.301 x | 3.87 x | -6.311 x | - | - | - |
| Free Cash Flow | - | -7 | 2.82 | 8.23 | -29.6 | -2.12 |
| ROE (net income / shareholders' equity) | - | 29.6% | -175% | -9.14% | -16% | -18.2% |
| ROA (Net income/ Total Assets) | - | 2.63% | -8.44% | 0.77% | -6.14% | -3.77% |
| Assets 1 | - | 150.5 | 139.3 | -469.9 | 191.3 | 279 |
| Book Value Per Share 2 | 0.5700 | 0.8300 | 0.0500 | 3.430 | 2.870 | 2.430 |
| Cash Flow per Share 2 | 0.4400 | 0.6600 | 0.6200 | 3.580 | 2.560 | 1.960 |
| Capex 1 | 1.06 | 2.37 | 1.54 | 2.82 | 5.61 | 5.44 |
| Capex / Sales | 0.81% | 1.38% | 1.12% | 1.85% | 3.1% | 2.48% |
| Announcement Date | 4/5/19 | 4/26/19 | 9/4/20 | 4/29/21 | 5/16/22 | 4/26/24 |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -76.96% | 4.08M | |
| +91.09% | 2,248B | |
| +41.48% | 661B | |
| +28.66% | 640B | |
| +34.56% | 211B | |
| +14.71% | 174B | |
| +49.77% | 138B | |
| -37.77% | 132B | |
| +51.27% | 121B | |
| +8.66% | 105B |
- Stock Market
- Equities
- VIAO Stock
- Financials VIA optronics AG